Lupin appoints Abdelaziz Toumi as CEO of its API CDMO subsidiary

hanuman

Active member
ep-lupin-big.jpg


Global pharma major Lupin (Lupin) announced the appointment of Abdelaziz Toumi (Abdel) as the Chief Executive Officer of its newly formed subsidiary, Lupin Manufacturing Solutions (LMS).

LMS is engaged in the development, manufacture and sale of Active Pharmaceutical Ingredients and is starting to build its Contract Development and Manufacturing Operations (CDMO) business.

Abdel, brings over two decades of experience in the biotech, pharma and CDMO sectors, spanning Europe, North America and Asia. Previously, he held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma. According to the statement, he will be based in Switzerland and will spend considerable time in India.



The post appeared first on .
 
Top
AdBlock Detected

We get it, advertisements are annoying!

Sure, ad-blocking software does a great job at blocking ads, but it also blocks useful features of our website. For the best site experience please disable your AdBlocker.

I've Disabled AdBlock